Activation of LIN-28B, a crucial RNA-binding protein, involves intricate mechanisms that impact its expression and functions within the cell. Several chemicals have been identified that can modulate LIN-28B activity, shedding light on potential strategies for its activation. Retinoic acid can effectively activate LIN-28B expression by binding to retinoic acid receptors, subsequently promoting LIN-28B transcription. This activation is particularly relevant in the context of embryonic development and cell differentiation. 5-Azacytidine offers another indirect route to activate LIN-28B by functioning as a DNA demethylating agent. This compound reduces DNA methylation at the LIN-28B promoter region, enhancing the accessibility of regulatory elements and facilitating LIN-28B expression. Trichostatin A, a histone deacetylase inhibitor, promotes LIN-28B expression by increasing histone acetylation at the LIN-28B gene locus. DMSO (Dimethyl Sulfoxide) acts as a solvent for certain LIN-28B-activating compounds, indirectly inducing LIN-28B expression. Sodium butyrate, another histone deacetylase inhibitor, indirectly activates LIN-28B expression by augmenting histone acetylation at its promoter.
Valproic acid, also an HDAC inhibitor, promotes LIN-28B expression by enhancing histone acetylation, contributing to the activation of this RNA-binding protein. 5-Aza-2'-deoxycytidine serves as a demethylating agent, reducing DNA methylation at the LIN-28B promoter and activating LIN-28B expression. TSA (Trichostatin A), a histone deacetylase inhibitor, increases LIN-28B expression by enhancing histone acetylation at the LIN-28B gene locus. Vorinostat, an HDAC inhibitor, can also promote LIN-28B expression by elevating histone acetylation levels. Decitabine, another demethylating agent, activates LIN-28B by reducing DNA methylation at its promoter region. Butyric acid indirectly activates LIN-28B expression by serving as a precursor to histone acetylation within the cell. Valproate, a histone deacetylase inhibitor, enhances LIN-28B expression by increasing histone acetylation levels at the LIN-28B gene locus.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can promote LIN-28B expression by increasing histone acetylation at the LIN-28B gene locus. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
DMSO can induce LIN-28B expression by acting as a solvent for certain LIN-28B-activating compounds. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase inhibitor, can indirectly activate LIN-28B expression by increasing histone acetylation at its promoter. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is another histone deacetylase inhibitor that can promote LIN-28B expression by enhancing histone acetylation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This demethylating agent can activate LIN-28B by reducing DNA methylation at the LIN-28B promoter. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, an HDAC inhibitor, can promote LIN-28B expression by increasing histone acetylation levels. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyric acid can indirectly activate LIN-28B expression by serving as a precursor to histone acetylation in the cell. | ||||||